Skip to content
10-Q

Quarterly Report

BIONOVATE TECHNOLOGIES CORP.

0001640334-21-002858

← back to feed
Filed
Nov 15, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Nov 4, 2021 7.75M sh
Operating Cash Flow Q1 2021 · Sep 30, 2021 $0
Operating Cash Flow Q1 2021 · Sep 30, 2020 $0
Long Term Debt Q1 2021 · Sep 30, 2021 $0
Long Term Debt Q1 2021 · Jun 30, 2021 $0
Cash And Equivalents Q1 2021 · Sep 30, 2021 $0
Cash And Equivalents Q1 2021 · Jun 30, 2021 $0
Cash And Equivalents Q1 2021 · Jun 30, 2020 $0
Stockholders Equity Q1 2021 · Sep 30, 2021 −$524.85K
Stockholders Equity Q1 2021 · Jun 30, 2021 −$503.21K
Stockholders Equity Q1 2021 · Sep 30, 2020 −$419.54K
Stockholders Equity Q1 2021 · Jun 30, 2020 −$396.67K
Current Liabilities Q1 2021 · Sep 30, 2021 $524.85K
Current Liabilities Q1 2021 · Jun 30, 2021 $503.21K
Total Liabilities Q1 2021 · Sep 30, 2021 $524.85K
Total Liabilities Q1 2021 · Jun 30, 2021 $503.21K
Current Assets Q1 2021 · Sep 30, 2021 $0
Current Assets Q1 2021 · Jun 30, 2021 $0
Total Assets Q1 2021 · Sep 30, 2021 $0
Total Assets Q1 2021 · Jun 30, 2021 $0
Net Income Q1 2021 · Sep 30, 2021 −$21.64K
Net Income Q1 2021 · Sep 30, 2020 −$22.87K
Operating Income Q1 2021 · Sep 30, 2021 −$6.28K
Operating Income Q1 2021 · Sep 30, 2020 −$3.62K
Revenue Q1 2021 · Sep 30, 2021 $0
Revenue Q1 2021 · Sep 30, 2020 $0